Legal & General Group
PAND

Legal & General Group’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Legal & General Group’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,299
Closed -$78K – 3784
2021
Q1 		$78K Buy
1,299
+488
+60% +$17.7K ﹤0.01% 2690
2020
Q4 		$12K Hold
811
– – ﹤0.01% 3292
2020
Q3 		$9K Buy
+811
New +$13.9K ﹤0.01% 3290

Legal & General Group's PAND Position: Q2 2021 in Review

Legal & General Group sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 1,299 shares — an estimated $78K sold.

Legal & General Group first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $78K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Legal & General Group reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 1,299 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $78K.
  • Legal & General Group first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Legal & General Group's Pandion Therapeutics Inc. Common Stock position peaked at $78K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.